Kilitch Drugs (India) Ltd KILITCH-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 2:59 PM IST
87.30quote price arrow down-0.45 (-0.51%)
Volume
5,498
52 week range
61.00 - 139.00

...

Loading . . .

KEY STATS

  • Open87.60
  • Day High88.05
  • Day Low86.40
  • Prev Close87.75
  • 52 Week High139.00
  • 52 Week High Date06/11/20
  • 52 Week Low61.00
  • 52 Week Low Date03/13/20
  • Market Cap18.41M
  • Shares Out15.49M
  • 10 Day Average Volume9,640.9
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-14.41

RATIOS/PROFITABILITY

  • EPS (TTM)1.11
  • P/E (TTM)78.60
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date09/20/2019
  • Div Amount0.50
  • Split Date-
  • Split Factor-

Latest Kilitch Drugs (India) Ltd News

There is no recent news for this security.

Latest KILITCH-IN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Kilitch Drugs (India) Limited is an India-based company, which is engaged in the development and operations of its pharmaceutical business. The Company primarily offers ONECEF INJ.1GM and KILITCH SRO 20.80GMS. The Company's parenteral solutions include Hyoce, Metoclop, K-Suxa, Kytoin, Artim, Neticin, Klavmox, Kilox, Clinda, Flork, Adron, Pivac, Ergomet, Kilmeta, Zovikil, Bivadin, Dexo, Dokine, Kain, K-Fol, Kiol, Vankom, Kabalin, Chlorpheniramine, Mectin, Cybuta, Onecef...
Sujit Dash
Chief Financial Officer
Address
Village: Savroli
Taluka: Khalapur, Dist: Raigad
Mumbai
400088
India